This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Verisk Health’s HEDIS Solution Fully Certified And Ready For The 2012 Season

Verisk Health announced that its HEDIS® Performance Measurement solution has been certified by the National Committee for Quality Assurance (NCQA) and is ready for 2012 Healthcare Effectiveness Data and Information Set (HEDIS) reporting. This year marks the 11 th straight season that the company has achieved full certification. Verisk Health is a global leader in risk management solutions and a long-standing NCQA® HEDIS Software Certification beta-testing partner.

“We’re pleased to once again deliver a fully-certified HEDIS solution so early in the 2012 reporting season,” said Nathan Gunn, MD, president of the Enterprise Analytics Division of Verisk Health. “And, we are excited to offer a solution optimized to further reduce run time, thereby providing the timely, monthly reporting that is critical to strategic initiatives such as Five Star quality improvement programs.”

To make sure that HEDIS stays current, the NCQA has established a process to update the measurements annually. The NCQA HEDIS Software Certification process requires solution providers to re-certify each year to ensure compliance with the latest quality measures. Verisk Health has a long-standing partnership with NCQA, achieving certification each year since 2001 and acting as a certification beta-testing vendor for the organization since 2003.

The Verisk Health HEDIS Performance Measurement solution is used by payers and providers to track, measure, and benchmark adherence to clinical standards. It enables managed care organizations to view results quickly and easily for each HEDIS measure, sample, and chase calculation performed. Key uses of the product include:
  • calculating HEDIS measures from source healthcare data
  • analyzing HEDIS data using robust filters, drills, and reports
  • collecting hybrid medical record data
  • developing custom measures for clinical reporting initiatives
  • access to secure, web-enabled software that facilitates the communication, planning, and managing of projects and checkpoints related to HEDIS measure production
  • access to chart review tools and services

Please join us February 22 from 1-2 p.m. Eastern time for a complimentary webinar entitled Improving Quality Outcomes Through Effective HEDIS Reporting. Click here to register

About Verisk Health

Verisk Health, a subsidiary of Verisk Analytics (Nasdaq:VRSK), helps organizations identify, manage, and mitigate healthcare risk to improve quality, reduce costs, and maximize profitability. Our data-driven risk assessment technologies and business decision analytics enable clients to proactively seize opportunities for improving clinical, financial, and performance results. Our solutions optimize the efficiency of key business objectives, including care management; risk identification and stratification; HEDIS compliance; benefit program measurement; fraud, waste, and abuse prevention; payment accuracy; and revenue cycle management. For more information, please visit

HEDIS® is a registered trademark of the NCQACertified HEDIS® Software is a service mark of the NCQAHEDIS® Software Certification is a service mark of the NCQA

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs